| Name | Title | Contact Details |
|---|
Community Medical Services is a CARF–accredited addiction treatment program providing services in the form of outpatient medication-assisted treatment and private one–on–one and group counseling, Intensive Out-Patient therapy (IOP) and Moral Reconation Therapy (MRT) to those seeking help with their substance use disorders. We have a total of 14 clinics throughout the United States. We have seven Arizona locations which cater to Phoenix, Glendale, Mesa, Scottsdale, and Tempe; a clinic in East Tucson, Northwest Tucson, Safford and Casa Grande; four clinics in Montana located in Missoula, Kalispell, Billings and Belgrade, which cater to clients in Bozeman and Helena; a clinic in Wasilla, Alaska catering to the Mat-Su Valley and Anchorage, and two clinics in North Dakota, one located in Minot, catering to clients in Williston and Bismarck and a clinic in Fargo, catering to clients from Fargo/Moorhead, West Fargo, Grand Forks, and Minnesota.
Jennings Center for Older Adults is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Jennings Center for Older Adults is based in Cleveland, OH. You can find more information on Jennings Center for Older Adults at www.jenningscenter.org
Althea Technologies, Inc., based in San Diego, CA, is focused on reducing the time, risk, and overall cost of our partner's drug development efforts. We apply immediate resources, unsurpassed scientific expertise, and a vast knowledge of regulatory
BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.